Published in Appl Environ Microbiol on October 01, 2006
Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology (2009) 2.56
Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol (2013) 1.25
LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol (2007) 1.25
Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci (2012) 1.00
Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage (2015) 0.92
Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens. Appl Microbiol Biotechnol (2010) 0.86
Bacteriophages and phage-derived proteins--application approaches. Curr Med Chem (2015) 0.83
Zif, the zoocin A immunity factor, is a FemABX-like immunity protein with a novel mode of action. Appl Environ Microbiol (2009) 0.83
In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother (2013) 0.81
Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile. Biotechnol Bioeng (2016) 0.76
Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species. Appl Environ Microbiol (2013) 0.76
Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev (1972) 19.14
Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science (1995) 4.27
Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. Proc Natl Acad Sci U S A (1967) 4.15
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
Bacteriophage endolysins--current state of research and applications. Curr Opin Microbiol (2005) 2.85
The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci (2003) 2.29
Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol (2005) 2.14
Amidase domains from bacterial and phage autolysins define a family of gamma-D,L-glutamate-specific amidohydrolases. Trends Biochem Sci (2003) 2.06
Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem (1999) 2.05
SH3 domains in prokaryotes. Trends Biochem Sci (1999) 1.91
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother (2005) 1.79
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob Agents Chemother (1999) 1.69
The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology (2004) 1.46
Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol (2006) 1.35
The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20
The separation of chondroitin sulfate disaccharides and hyaluronan oligosaccharides by capillary zone electrophoresis. Anal Biochem (1991) 1.04
Engineering disease resistant cattle. Transgenic Res (2005) 0.96
Characterization of LytH, a differentiation-associated peptidoglycan hydrolase of Bacillus subtilis involved in endospore cortex maturation. J Bacteriol (2003) 0.93
Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol (2007) 7.44
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol Ther (2009) 2.25
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle (2010) 1.96
Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem (2004) 1.92
Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. Liver Int (2009) 1.48
The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology (2004) 1.46
Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol (2006) 1.35
Endolysins as antimicrobials. Adv Virus Res (2012) 1.33
LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett (2008) 1.30
LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol (2007) 1.25
Polyglycylation domain of beta-tubulin maintains axonemal architecture and affects cytokinesis in Tetrahymena. Nat Cell Biol (2002) 1.25
Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res (2010) 1.23
The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20
A novel glucosyltransferase is required for glycosylation of a serine-rich adhesin and biofilm formation by Streptococcus parasanguinis. J Biol Chem (2010) 1.14
Anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2008) 1.14
Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res (2009) 1.06
Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol (2010) 1.05
A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model. J Bacteriol (2008) 1.05
A conserved domain of previously unknown function in Gap1 mediates protein-protein interaction and is required for biogenesis of a serine-rich streptococcal adhesin. Mol Microbiol (2008) 1.03
Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies. Tumori (2010) 1.03
Characterization of the enzymes encoded by the anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2010) 0.98
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res (2012) 0.96
PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. Am J Pathol (2010) 0.95
Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression. Cancer Res (2011) 0.92
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Res (2013) 0.92
Signal transducer and activator of transcription-3 and breast cancer prognosis. Am J Cancer Res (2011) 0.91
Global profiling of prolactin-modulated transcripts in breast cancer in vivo. Mol Cancer (2013) 0.90
The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem J (2002) 0.90
STAT5A/B gene locus undergoes amplification during human prostate cancer progression. Am J Pathol (2013) 0.84
Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells. J Biol Chem (2013) 0.84
Melanoma cell-secreted soluble factor that stimulates ubiquitination and degradation of the interferon alpha receptor and attenuates its signaling. Pigment Cell Melanoma Res (2010) 0.84
The effect of mannan oligosaccharide supplementation on body weight gain and fat accrual in C57Bl/6J mice. Obesity (Silver Spring) (2009) 0.83
Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Res Treat (2011) 0.83
Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies. Liver Int (2012) 0.81
Identification of the UDP-N-acetylglucosamine 4-epimerase involved in exosporium protein glycosylation in Bacillus anthracis. J Bacteriol (2009) 0.81
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Res (2013) 0.80
Cleavage specificity of Enterococcus faecalis EnpA (EF1473), a peptidoglycan endopeptidase related to the LytM/lysostaphin family of metallopeptidases. J Mol Biol (2010) 0.78
Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III. Vaccine (2012) 0.78
Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells. Cancer Lett (2010) 0.76
Cattle transport in the UK. Vet Rec (2002) 0.75
DEFRA/ADAS animal welfare promotion. Vet Rec (2004) 0.75